A newly ausculted heart murmur is a common encounter in general practice, but navigating what comes next isn’t always straightforward. In this episode of the Partner Podcast, Dr. Lance Visser, board-certified veterinary cardiologist, breaks down the essentials of myxomatous mitral valve disease, including staging and diagnostic criteria, the landmark EPIC trial data, and what the recent approval of VETMEDIN® (pimobendan) by the FDA for the preclinical B2 dogs means for clinical practice. Sponsored by Boehringer Ingelheim This podcast is RACE-approved for 1 hour of CE credit through August 5, 2028. Earn your CE credit here: https://cliniciansbrief.com/continuing-education/syllabus/lesson/b2-dog-every-general-practitioner-should-know-preclinical-heart-disease-dr-visser Contact us: Podcast@instinct.vet Where to find us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ X: @cliniciansbrief Instagram: @clinicians.brief The Team: Beth Molleson, DVM - Host Sarah Pate - Producer & Project Manager, Brief Studio Taylor Argo- Podcast Production & Sound Editing
A newly ausculted heart murmur is a common encounter in general practice, but navigating what comes next isn’t always straightforward. In this episode of the Partner Podcast, Dr. Lance Visser, board-certified veterinary cardiologist, breaks down the essentials of myxomatous mitral valve disease, including staging and diagnostic criteria, the landmark EPIC trial data, and what the recent approval of VETMEDIN® (pimobendan) by the FDA for the preclinical B2 dogs means for clinical practice.
Sponsored by Boehringer Ingelheim
This podcast is RACE-approved for 1 hour of CE credit through August 5, 2028. Earn your CE credit here.
Contact us:
Where to find us:
The Team: